Pharmaceutical compositions for the treatment of capillary...

Details Pharmaceutical compositions for the treatment of capillary... Pharmaceutical compositions for the treatment of capillary...

A - Human Necessities

61

K

A61K 31/48 (2006.01) A61K 31/00 (2006.01) A61P 9/08 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2670846

The invention relates to the use of ergot derivatives or ergolines and particularly lisuride and terguride for preventing and treating constrictive capillary arteriopathy, a term that encompasses pulmonary arterial hypertension, endogenously or exogenously induced glomeruloscleroses, and secondary Raynaud's phenomenon or syndrome.

L'invention concerne l'utilisation de dérivés d'ergot ou d'ergolines, notamment de lisuride et de terguride, pour la prophylaxie et le traitement de l'artériopathie capillaire constrictive. L'artériopathie capillaire constrictive désigne dans ce cas des maladies d'hypertension artérielle pulmonaire, des gloméruloscléroses d'origine endogène ou exogène, et le phénomène ou le syndrome de Raynaud secondaire.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions for the treatment of capillary... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions for the treatment of capillary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for the treatment of capillary... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1581424